Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'hth 01 015'

Search results for: 'hth 01 015'

Items 1-10 of 105

Page
per page
  1. TA 01
    B4923 TA 01
    Summary: CK1ε, CK1δ,and p38α inhibitor
      insoluble in H2O; insoluble in EtOH; ≥12.75 mg/mL
  2. PG 01
    B7545 PG 01
    Summary: CFTR mutants potentiator
      <43.95 mg/mL
  3. HTH-01-015
    A8890 HTH-01-015
    Target: NUAK
    Summary: NUAK1 inhibitor,highly specific and selective
      ≥23.45 mg/mL
  4. AT 1015
    B5609 AT 1015
    Summary: Long-acting 5-HT2A antagonist
      <49.2 mg/mL
  5. BI 6015
    B5668 BI 6015
    Summary: HNF4α antagonist
      Soluble in DMSO
  6. EPZ015666
    B4989 EPZ015666
    Target: Protein Arginine Methyltransferases
    Summary: PRMT5 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.17 mg/mL
  7. Peficitinb (ASP015K, JNJ-54781532)
    B6005 Peficitinb (ASP015K, JNJ-54781532)
    Summary: JAK inhibitor
      ≥23.2 mg/mL
  8. Bephenium Hydroxynaphthoate
    A8376 Bephenium Hydroxynaphthoate
    Summary: Anthelmintic agent
      insoluble in H2O; insoluble in EtOH; ≥20.85 mg/mL
  9. 1-Naphthyl PP1
    A8605 1-Naphthyl PP1
    Summary: Src family kinases inhibitor
      ≥25.32 mg/mL
  10. I-BET151 (GSK1210151A)
    B1500 I-BET151 (GSK1210151A)
     2 Citation
    Target: Bromodomain and Extra-Terminal motif (BET)
    Summary: Selective BET inhibitor
      ≥41.5 mg/mL

Items 1-10 of 105

Page
per page